These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20191265)

  • 1. Pyrogallol-induced As4.1 juxtaglomerular cell death is attenuated by MAPK inhibitors via preventing GSH depletion.
    Han YH; Park WH
    Arch Toxicol; 2010 Aug; 84(8):631-40. PubMed ID: 20191265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Moon HJ; You BR; Park WH
    Food Chem Toxicol; 2010 Jan; 48(1):271-6. PubMed ID: 19833163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
    You BR; Park WH
    J Agric Food Chem; 2011 Jan; 59(2):763-71. PubMed ID: 21166414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A superoxide anion generator, pyrogallol induces apoptosis in As4.1 cells through the depletion of intracellular GSH content.
    Park WH; Han YW; Kim SH; Kim SZ
    Mutat Res; 2007 Jun; 619(1-2):81-92. PubMed ID: 17382355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 inhibitor intensified cell death in antimycin A-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Anticancer Res; 2009 Nov; 29(11):4423-31. PubMed ID: 20032388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The changes of intracellular H2O2 are an important factor maintaining mitochondria membrane potential of antimycin A-treated As4.1 juxtaglomerular cells.
    Han YW; Kim SZ; Kim SH; Park WH
    Biochem Pharmacol; 2007 Mar; 73(6):863-72. PubMed ID: 17174941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular glutathione levels are involved in carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone-induced apoptosis in As4.1 juxtaglomerular cells.
    Han YH; Park WH
    Int J Mol Med; 2011 Apr; 27(4):575-81. PubMed ID: 21258765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.
    Park WH
    Oncol Rep; 2012 May; 27(5):1611-8. PubMed ID: 22293863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with p38 inhibitor intensifies the death of MG132-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.
    Han YH; Kim SZ; Kim SH; Park WH
    Drug Chem Toxicol; 2010 Oct; 33(4):367-76. PubMed ID: 20545600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrogallol-induced calf pulmonary arterial endothelial cell death via caspase-dependent apoptosis and GSH depletion.
    Han YH; Park WH
    Food Chem Toxicol; 2010 Feb; 48(2):558-63. PubMed ID: 19913593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrogallol, ROS generator inhibits As4.1 juxtaglomerular cells via cell cycle arrest of G2 phase and apoptosis.
    Park WH; Han YH; Kim SH; Kim SZ
    Toxicology; 2007 Jun; 235(1-2):130-9. PubMed ID: 17442475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyrogallol-induced endothelial cell death is related to GSH depletion rather than ROS level changes.
    Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH
    Oncol Rep; 2010 Jan; 23(1):287-92. PubMed ID: 19956894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic trioxide inhibits growth of As4.1 juxtaglomerular cells via cell cycle arrest and caspase-independent apoptosis.
    Han YH; Kim SZ; Kim SH; Park WH
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F511-20. PubMed ID: 17507598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion.
    Han YH; Kim SH; Kim SZ; Park WH
    Int J Oncol; 2008 Nov; 33(5):1099-105. PubMed ID: 18949374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis in pyrogallol-treated Calu-6 cells is correlated with the changes of intracellular GSH levels rather than ROS levels.
    Han YH; Kim SZ; Kim SH; Park WH
    Lung Cancer; 2008 Mar; 59(3):301-14. PubMed ID: 17920721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of MAPK inhibitors and ROS modulators on cell growth and death of H₂O₂-treated HeLa cells.
    Park WH
    Mol Med Rep; 2013 Aug; 8(2):557-64. PubMed ID: 23799549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrogallol as a glutathione depletor induces apoptosis in HeLa cells.
    Han YH; Kim SZ; Kim SH; Park WH
    Int J Mol Med; 2008 Jun; 21(6):721-30. PubMed ID: 18506365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular GSH level is a factor in As4.1 juxtaglomerular cell death by arsenic trioxide.
    Han YH; Kim SZ; Kim SH; Park WH
    J Cell Biochem; 2008 Jun; 104(3):995-1009. PubMed ID: 18247324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.
    Park WH; Kim SH
    Oncol Rep; 2013 Jul; 30(1):513-9. PubMed ID: 23660987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.